On the other hand, beneficial actions have also been proposed for visfatin/Nampt, since the administration of visfatin/Nampt has shown beneficial effects in ischemia-related clinical conditions, such as stroke, peripheral limb ischemia, or myocardial ischemia-reperfusion, where it may become a beneficial pharmacological tool. The gene discussed is NAMPT; the disease is ischemia.